BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 773181)

  • 1. An evaluation of the teratogenicity of certain antinauseant drugs.
    Milkovich L; van den Berg BJ
    Am J Obstet Gynecol; 1976 May; 125(2):244-8. PubMed ID: 773181
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CDC study: no evidence for teratogenicity of Bendectin.
    Check WA
    JAMA; 1979 Dec; 242(23):2518. PubMed ID: 490865
    [No Abstract]   [Full Text] [Related]  

  • 3. Safety and efficacy of antiemetics used to treat nausea and vomiting in pregnancy.
    Leathem AM
    Clin Pharm; 1986 Aug; 5(8):660-8. PubMed ID: 2874910
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A new pharmacologic treatment for nausea and vomiting of pregnancy.
    Fantasia HC
    Nurs Womens Health; 2014; 18(1):73-77. PubMed ID: 24548499
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bendectin and fetal development. A study of Boston City Hospital.
    Morelock S; Hingson R; Kayne H; Dooling E; Zuckerman B; Day N; Alpert JJ; Flowerdew G
    Am J Obstet Gynecol; 1982 Jan; 142(2):209-13. PubMed ID: 7055187
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety of drug therapy for nausea and vomiting of pregnancy.
    Huff PS
    J Fam Pract; 1980 Nov; 11(6):969-70. PubMed ID: 7005391
    [No Abstract]   [Full Text] [Related]  

  • 7. Bendectin: a case of mourning sickness.
    Hays DP
    Drug Intell Clin Pharm; 1983 Nov; 17(11):826-7. PubMed ID: 6641507
    [No Abstract]   [Full Text] [Related]  

  • 8. Evaluation of the teratogenic effect of meclizine in man.
    Yerushalmy J; Milkovich L
    Am J Obstet Gynecol; 1965 Oct; 93(4):553-62. PubMed ID: 5891549
    [No Abstract]   [Full Text] [Related]  

  • 9. Is Bendectin a teratogen?
    Cordero JF; Oakley GP; Greenberg F; James LM
    JAMA; 1981 Jun; 245(22):2307-10. PubMed ID: 7230458
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bendectin.
    DeSesso JM
    Reprod Toxicol; 2001; 15(6):733. PubMed ID: 11738529
    [No Abstract]   [Full Text] [Related]  

  • 11. The creation of therapeutic orphans--or, what have we learnt from the Debendox fiasco?
    Sheffield LJ; Batagol R
    Med J Aust; 1985 Aug; 143(4):143-7. PubMed ID: 3927122
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bendectin/diclectin for morning sickness: a Canadian follow-up of an American tragedy.
    Ornstein M; Einarson A; Koren G
    Reprod Toxicol; 1995; 9(1):1-6. PubMed ID: 8520127
    [No Abstract]   [Full Text] [Related]  

  • 13. Misleading meta-analyses of observational studies may generate unjustified alarms: The case of medications for nausea and vomiting in pregnancy.
    Biffi A; Rea F; Locatelli A; Cetin I; Filippelli A; Corrao G
    Pharmacol Res; 2021 Jan; 163():105229. PubMed ID: 33031909
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bendectin: review of the medical literature of a comprehensively studied human nonteratogen and the most prevalent tortogen-litigen.
    Scialli AR
    Reprod Toxicol; 1999; 13(4):239. PubMed ID: 10453907
    [No Abstract]   [Full Text] [Related]  

  • 15. Measuring drug effectiveness by default: the case of Bendectin.
    Neutel CI; Johansen HL
    Can J Public Health; 1995; 86(1):66-70. PubMed ID: 7728721
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alternative therapies of morning sickness.
    Strong TH
    Clin Obstet Gynecol; 2001 Dec; 44(4):653-60. PubMed ID: 11600848
    [No Abstract]   [Full Text] [Related]  

  • 17. Congenital anomalies in relation to the use of doxylamine/dicyclomine and other antenatal factors: an ongoing prospective study.
    Gibson GT; Colley DP; McMichael AJ; Hartshorne JM
    Med J Aust; 1981 Apr; 1(8):410-4. PubMed ID: 7254087
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [2 cases of malformations of a limb in infants of mothers treated with an antiemetic in a very early phase of pregnancy].
    Soverchia G; Perri PF
    Pediatr Med Chir; 1981; 3(1):97-9. PubMed ID: 7301625
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New evidence for concern over the risk of birth defects from medications for nausea and vomitting of pregnancy.
    BĂ©rard A; Sheehy O; Gorgui J; Zhao JP; Soares de Moura C; Bernatsky S
    J Clin Epidemiol; 2019 Dec; 116():39-48. PubMed ID: 31352006
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Admissibility of scientific testimony into evidence.
    Brushwood DB
    Am J Hosp Pharm; 1994 Mar; 51(5):683-5. PubMed ID: 8203391
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.